Biblio Discovery — Demo Discovery Service

404 hasil

Menampilkan 1–20 · 0,01 detik · RSS

Jurnal

Exploration of Targeted Anti-tumor Therapy

Scopus

ISSN 2692-3114 · Open Exploration Publishing Inc. · 404 artikel di indeks

  1. Artikel Jurnal Teks lengkap

    Application of explainable artificial intelligence integrating with electronic health record in oncology

    Yuhan Yang; Xici Liu

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Machine learning (ML) and deep learning (DL) models applied to electronic health records (EHRs) have substantial potential to improve oncology care across diagnosis, prognosis, treatment selection, and trial recruitment. However, opacity of many high-performing models limits clinician trust…

  2. Artikel Jurnal Teks lengkap

    Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer

    Ogochukwu O. Izuegbuna

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Breast cancer is a leading cause of cancer death in women worldwide. One of the major causes of death from breast cancer is metastatic disease, which results from the malignant cells invading and migrating through blood vessels to distant sites. Several studies have shown that metastasis is…

  3. Artikel Jurnal Teks lengkap

    Glioblastoma pathophysiology: roles of aging driven changes in STAT3 interactions with NF-κB dimer components in the modulation of the mitochondrial melatonergic pathway and night-time inflammation resolution

    George Anderson

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Glioblastoma (GBM) is a complex condition with a poorly understood pathophysiology and no effective treatment to date. The present article highlights the role of canonical and non-canonical signal transducer and activator of transcription 3 (STAT3) interactions with nuclear factor…

  4. Artikel Jurnal Teks lengkap

    Addition of immune checkpoint inhibitor to standard of care chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis

    Ramaditya Srinivasmurthy; Jason Ta; Sharif Afifi dkk.

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Background: Preliminary findings from this study were previously published as a conference abstract (https://doi.org/10.1158/2326-6074.IO2025-B039). Immune checkpoint inhibitors (ICIs) have shown activity in nasopharyngeal carcinoma (NPC), but their efficacy and safety when integrated with standard…

  5. Artikel Jurnal Teks lengkap

    Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution

    Kei Nakagawa; Hideaki Sato; Masahiro Iseki dkk.

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Aim: Treatment approaches for biliary tract cancer (BTC) vary widely. Genomic profiling through next-generation sequencing (NGS) has made it possible to apply precision medicine in the management of BTC. This retrospective observational study aimed to evaluate the implementation of treatments based…

  6. Artikel Jurnal Teks lengkap

    Cardiotoxicity in breast cancer patients treated with chemoradiotherapy

    Peter Emerson; Liza Thomas

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    With national breast cancer screening programs leading to earlier diagnosis and improved treatments, more women are achieving long-term remission. However, this has resulted in rising rates of cardiotoxicity in breast cancer survivors consequent to their cancer therapies. Anthracyclines, a…

  7. Artikel Jurnal Teks lengkap

    Post-CDK4/6 inhibitor therapy in HR+/HER2– advanced breast cancer: expanding options and persisting uncertainties

    Anne-Murielle Hollinger; Ruben Bill

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Endocrine treatment in combination with CDK4/6 inhibitors represents the mainstay of first-line palliative treatment in HR+/HER2– breast cancer. The treatment landscape after progression on CDK4/6 inhibitors has evolved into a complex and rapidly evolving field, driven by novel endocrine and…

  8. Artikel Jurnal Teks lengkap

    Impact of smoking on subtypes and molecular profile of breast cancer: a systematic review

    Georgia Ntella; Anastasia Bothou; Giannoula Kyrkou dkk.

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Background: Breast cancer encompasses heterogeneous pathological and molecular subtypes with distinct aetiologies and clinical outcomes. Although cigarette smoking is an established carcinogenic exposure, its subtype-specific associations and molecular effects in breast cancer remain insufficiently…

  9. Artikel Jurnal Teks lengkap

    The evolution of chemotherapy in brain tumors: from historical milestones to precision medicine in glioblastoma

    Alessia Ciafarone; Paola Palumbo

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Chemotherapy has profoundly shaped modern oncology, evolving from early cytotoxic approaches to biologically informed strategies. In glioblastoma (GBM), the highly aggressive primary brain tumor, precision medicine does not rely on the identification of a single crucial oncogenic driver but…

  10. Artikel Jurnal Teks lengkap

    RNA therapeutic targeting of recalcitrant and rare cancers

    Afeez Adekunle Ishola; Nalini Devi Verusingam; Bashir Lawal

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    In 2013, more than a decade ago, the “Recalcitrant Cancer Research Act of 2012” was signed into law in the USA. Recalcitrant cancers are among the leading causes of global cancer morbidity and mortality. At the inception of the act, priority was placed on lungs and pancreatic cancers. Despite the…

  11. Artikel Jurnal Teks lengkap

    Triple-negative breast cancer: current understanding and future perspectives

    Alhasan Alobaidi; Vikrant Rai

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype defined by the absence of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2) expression. Consequently, standard hormone and HER2-targeted therapies are ineffective, necessitating…

  12. Artikel Jurnal Teks lengkap

    ESR1 mutations in ER-positive breast cancer: from endocrine resistance to ctDNA-guided therapeutic interception

    Thais Martinez; Samantha Wegner; Hisham F. Bahmad

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Endocrine resistance in estrogen receptor-positive (ER+) breast cancer has undergone a fundamental reconceptualization over the past decade. The discovery that activating mutations in the ESR1 gene encoding ERα emerge under aromatase inhibitor (AI) selection pressure and drive ligand-independent…

  13. Artikel Jurnal Teks lengkap

    Response-adaptive breast cancer care in the grey zones: integrating ER and HER2 targeted PET, FDG PET/CT under immunotherapy, and ctDNA kinetics

    Jovana Zivanovic; Jules Zhang-Yin

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Breast cancer management increasingly hinges on decisions made in “grey zones” where tissue sampling is scarce, and tumour biology evolves under therapeutic pressure. This narrative review synthesises evidence on how whole-body imaging biomarkers and circulating tumour DNA (ctDNA) can support…

  14. Artikel Jurnal Teks lengkap

    Bioethical challenges in the implementation of targeted anti-tumor therapies in low-resource settings: a perspective from Latin America

    Alcides Chaux

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Precision oncology has revolutionized cancer care in high-income countries, but its implementation in Latin American low-resource settings faces profound bioethical dilemmas. This study analyzes these challenges through the lens of social justice and equity. An integrative review was conducted…

  15. Artikel Jurnal Teks lengkap

    Liquid biopsy in breast cancer: current biomarker platforms and clinical applications

    Pritam Saha Podder; Debasree Bhadra; Canio Martinelli dkk.

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Breast cancer remains one of the leading causes of cancer-related mortality worldwide, and despite considerable advances in therapeutic strategies, the absence of reliable, minimally invasive diagnostic tools continues to limit early detection and real-time disease monitoring. Liquid biopsy has…

  16. Artikel Jurnal Teks lengkap

    Safety and efficacy of delivering systemic treatments concomitantly with whole-brain radiotherapy: a prospective, observational, single-institution study

    Maria Protopapa; Kalliopi Platoni; Michalis Psarras dkk.

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Aim: The aim of our study was to evaluate the safety and efficacy of delivering systemic treatments concurrently with whole-brain radiotherapy (WBRT). Methods: A single-institution, prospective observational study was conducted in Athens, Greece, including 99 patients treated with WBRT for brain…

  17. Artikel Jurnal Teks lengkap

    Transcriptional modulation of the PI3K/AKT/mTOR signaling pathway mediated by HPV16 E5, E6, and E7 oncogene expression in breast cancer

    Beatriz Eda de Oliveira Isídio; Pedro Henrique Bezerra Fontes; Gabriel Rômulo Parente da Silva dkk.

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Aim: Breast cancer is the most prevalent malignant tumor among women. Human papillomavirus (HPV) has been detected in breast tumors since the 1990s, and beyond its oncogenic potential, therapy resistance driven by viral immune evasion in non-anogenital tumors, such as oropharyngeal cancers…

  18. Artikel Jurnal Teks lengkap

    Precision oncology in the treatment of patients with bone sarcomas: an up-to-date narrative review

    Sude Yarar; Panagiotis Tsagkozis

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Primary bone sarcomas are rare and biologically heterogeneous malignancies for which therapeutic progress remains limited, particularly in metastatic and recurrent disease. Advances in genomic and molecular profiling have revealed substantial inter- and intratumoral heterogeneity across the major…

  19. Artikel Jurnal Teks lengkap

    Dendritic cell-based immunotherapy modulates the systemic inflammatory profile in a 4T1 breast cancer model

    Tauana Christina Dias; Jéssica Ferreira Vieira; Katiane Tostes dkk.

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Aim: Breast cancer remains a major cause of cancer-related mortality in women, particularly in advanced stages where therapeutic options are limited. While immune checkpoint inhibitors (ICIs) have improved outcomes in a subset of patients, many do not respond, highlighting the need for alternative…

  20. Artikel Jurnal Teks lengkap

    Consensus statements on the definition, diagnosis, and management of oligoprogressive disease: results of an expert survey of Kazakhstan Cancer Society

    Dilyara Kaidarova; Indira Omarova; Samat Kaldarbekov dkk.

    Exploration of Targeted Anti-tumor Therapy, Vol. 7 · 2026 · Inggris · DOAJ Scopus

    Aim: Oligoprogressive disease (OPD) has emerged as a clinically relevant and common scenario in oncology, reflecting progression in a limited number of metastatic sites while systemic therapy continues to control the majority of disease. Despite its increasing recognition, the definition…